Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.70 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.64 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.64 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.64 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.64 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.64 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.64 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.64 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.64 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.64 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL100952 | 0.91 | NR4A2 (0.65) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL133319 | 0.90 | HDAC1 (0.75) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL29670519 | 0.89 | GSK3B (0.57) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL6286372 | 0.89 | GSK3B (0.57) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL16499440 | 0.89 | GSK3B (0.57) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL3840781 | 0.88 | GSK3B (0.68) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL25894500 | 0.88 | ALDH1A1 (0.65) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL15348715 | 0.87 | GSK3B (0.55) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL2116189 | 0.86 | HSD17B3 (0.67) | GSK3BHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL20799581 | 0.86 | GSK3B (0.59) | GSK3BHDAC1HDAC8HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4357332-B1 | COMPOUND, PREPARATION METHOD THEREFOR, USE THEREOF, AND PEROVSKITE SOLAR CELL COMPRISING SAME | CONTEMPORARY AMPEREX TECHNOLOGY HONG KONG LTD (HK) | 2026-04-22 | — | — | EP | disclosed |
| US-12439765-B2 | Compound, preparation method and use thereof and perovskite solar cell containing same | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-10-07 | — | — | US | disclosed |
| CN-115819365-B | Organic compound, solar cell and preparation method thereof | 宁德时代新能源科技股份有限公司 | 2024-10-18 | — | — | CN | disclosed |
| US-20240292639-A1 | COMPOUND, PREPARATION METHOD AND USE THEREOF AND PEROVSKITE SOLAR CELL CONTAINING SAME | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2024-08-29 | — | — | US | disclosed |
| CN-118556040-A | Compound, preparation method and application thereof, and perovskite solar cell comprising compound | 宁德时代新能源科技股份有限公司 | 2024-08-27 | — | — | CN | disclosed |
| EP-4357332-A1 | COMPOUND, PREPARATION METHOD THEREFOR, USE THEREOF, AND PEROVSKITE SOLAR CELL COMPRISING SAME | Contemporary Amperex Technology Co., Limited (CN) | 2024-04-24 | — | — | EP | disclosed |
| CN-115403459-B | Preparation method of 1, 4-dicarbonyl compound | 广州自远生物科技有限公司 | 2024-02-27 | — | — | CN | disclosed |
| WO-2024016317-A1 | COMPOUND, PREPARATION METHOD THEREFOR, USE THEREOF, AND PEROVSKITE SOLAR CELL COMPRISING SAME | 宁德时代新能源科技股份有限公司 | 2024-01-25 | — | — | WO | disclosed |
| US-20230285378-A1 | Anti-Viral Compounds | ABBVIE INC. (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230285378-A1 | Anti-Viral Compounds | ABBVIE INC. (US) | 2023-09-14 | — | — | US | disclosed |
| EP-0792271-B1 | FURAN DERIVATIVES FOR INHIBITING PNEUMOCYSTIS CARINII PNEUMONIA, GIARDIA LAMBLIA AND CRYPTOSPORIDIUM PARVUM | UNIV GEORGIA STATE RES FOUND (US) | 2002-02-27 | — | — | EP | disclosed |
| US-5723288-A | Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans, and kits useful therefor | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1998-03-03 | — | — | US | disclosed |
| US-5667975-A | Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans | THE UNIVERSITY OF NORTH CAROLINA | 1997-09-16 | — | — | US | disclosed |
| EP-0792271-A1 | FURAN DERIVATIVES FOR INHIBITING PNEUMOCYSTIS CARINII PNEUMONIA, GIARDIA LAMBLIA AND CRYPTOSPORIDIUM PARVUM | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1997-09-03 | — | — | EP | disclosed |
| EP-0758453-A1 | METHOD OF FLUORESCENT DETECTION OF NUCLEIC ACIDS AND CYTOSKELETON ELEMENTS USING BIS-DICATIONIC ARYL FURANS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1997-02-19 | — | — | EP | disclosed |
| US-5602172-A | USING A 2,5-DIPHENYLFURAN COMPOUND | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1997-02-11 | — | — | US | disclosed |
| US-5594138-A | MEDICAL DIAGNOSIS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1997-01-14 | — | — | US | disclosed |
| WO-1996040997-A1 | METHOD OF FLUORESCENT DETECTION OF NUCLEIC ACIDS AND CYTOSKELETON ELEMENTS USING BIS-DICATIONIC ARYL FURANS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996015126-A1 | FURAN DERIVATIVES FOR INHIBITING PNEUMOCYSTIS CARINII PNEUMONIA, GIARDIA LAMBLIA AND CRYPTOSPORIDIUM PARVUM | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
| WO-1995030901-A1 | METHOD OF FLUORESCENT DETECTION OF NUCLEIC ACIDS AND CYTOSKELETON ELEMENTS USING BIS-DICATIONIC ARYL FURANS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1995-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12439765-B2 | Compound, preparation method and use thereof and perovskite solar cell containing same | SLC9B2, SLC9A2, SLC9A5 | GSK3B 2257/4885HDAC1 4289/4885HDAC8 4537/4885 |
| US-20230285378-A1 | Anti-Viral Compounds | HAVCR2, EIF2AK2, MAVS | GSK3B 665/4885HDAC1 1199/4885HDAC8 1304/4885 |
| US-20240292639-A1 | COMPOUND, PREPARATION METHOD AND USE THEREOF AND PEROVSKITE SOLAR CELL CONTAINING SAME | SLC9B2, SLC9A2, SLC9A5 | GSK3B 2257/4885HDAC1 4289/4885HDAC8 4537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.